A- A A+

USA. Teva to Donate Over $15 Bln Worth of Drugs in Opioid Settlement - Source

Teva Pharmaceuticals is in talks to contribute over $15 billion worth of drugs as part of a settlement to resolve lawsuits alleging it helped fuel the U.S. opioid crisis, a source familiar with the matter told Reuters on Wednesday. (Reuters, 18.10.2019)

https://www.medscape.com/viewarticle/919950

USA/Kanada. Aurora Cannabis Is Dumping Its Pot, Which May Be A Sign It’s All Over 

(…) companies like Aurora Cannabis (ACB) are “dumping” part of their harvest… because they simply grew more pot than they could sell at a reasonable price. (Forbes, USA, 21.10.2019)

https://www.forbes.com/sites/stephenmcbride1/2019/10/21/aurora-cannabis-is-dumping-its-pot-which-may-be-a-sign-its-all-over/#797dcd205775

USA. Four big drug firms agree to $260m opioid payout hours before trial set to begin 

Teva and three drug distributors in last-minute settlement. Firms were to be accused of profiting from addiction and death. (The Guardian, UK, 21.10.2019)

https://www.theguardian.com/us-news/2019/oct/21/opioid-makers-drug-industry-trial-cleveland-ohio

The Germany Cannabis Report

The Germany Cannabis Report is the first and only free-to-access report to focus on the biggest economy in Europe and its burgeoning cannabis market. Having legalised medical cannabis in 2017 and achieved a market value of over €73 million in 2018, Germany is set to play a central role in the European market in the coming years, which is estimated to be worth over €123 billion by 2028. (Prohibition Partners, London-Barcelona-Dublin, Oktober 2019)

https://prohibitionpartners.com/reports/

Immer höhere Preise im Pharmamarkt

Pressekonferenz der Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) und des Wissenschaftlichen Instituts der AOK (WIdO) 24. September 2019, Berlin

Statement von Jürgen Klauber, Geschäftsführer des Wissenschaftlichen Instituts der AOK (WIdO)

https://aok-bv.de/imperia/md/aokbv/presse/pressemitteilungen/archiv/pk_avreport_2019_statement_klauber.pdf

USA. Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlement

STAMFORD, Conn., September 15, 2019. Purdue’s entire value to be contributed for the benefit of the American public. Settlement is estimated to provide more than $10 billion of value to address opioid crisis, including potentially contributing millions of doses of life-saving opioid overdose reversal medications. Purdue to use Chapter 11 reorganization to finalize and implement settlement agreement.

https://www.purduepharma.com/news/2019/09/16/purdue-pharma-announces-agreement-in-principle-on-landmark-opioid-litigation-settlement/

USA. Purdue Pharma L.P. 

https://www.purduepharma.com/

USA. US-Bundesstaaten klagen gegen Millionen-Boni von Purdue Pharma

New York – Ein Bündnis von US-Bundesstaaten geht rechtlich gegen millionenschwere Boni-Pläne des umstrittenen Schmerzmittel-Herstellers Purdue Pharma vor. Es gehe um Sondervergütungen in Höhe von 38 Millionen Dollar (34,6 Mio Euro), die das Unternehmen trotz seines Insolvenzantrags auszahlen wolle, teilte New Yorks Generalstaatsanwältin Letitia James gestern mit. (aerzteblatt.de, 04.10.2019)

https://www.aerzteblatt.de/nachrichten/106458/US-Bundesstaaten-klagen-gegen-Millionen-Boni-von-Purdue-Pharma

USA. Johnson & Johnson stimmt in US-Opioid-Krise Millionen-Vergleich zu

Washington – In der Opioid-Krise in den USA hat der Arzneimittel-Hersteller Johnson & Johnson einem Millionenvergleich zugestimmt. (...) Damit entgeht J&J einem Großprozess. (aerzteblatt.de, 02.10.2019)

https://www.aerzteblatt.de/nachrichten/106435/Johnson-Johnson-stimmt-in-US-Opioid-Krise-Millionen-Vergleich-zu

USA. Purdue Pharma Settlement a “Stopgap” For Areas Hardest Hit by Opioid Crisis: Report

The proposed settlement with OxyContin maker Purdue Pharma is “no more than a stopgap for local and state governments,” which will continue to face costs related to the opioid crisis that far exceed the agreed upon amounts, according to a new report by Moody’s Investors Services. (Partnership News Service Staff, USA, 26.09.2019)

https://drugfree.org/learn/drug-and-alcohol-news/purdue-pharma-settlement-a-stopgap-for-areas-hardest-hit-by-opioid-crisis-report

USA. House passes bill that would allow banks to work with cannabis companies

The U.S. House of Representatives voted Wednesday to advance legislation that would allow banks to provide services to cannabis companies in states where it is legal. (Reuters, 26.09.2019)

https://www.reuters.com/article/us-usa-house-cannabis/house-passes-bill-that-would-allow-banks-to-work-with-cannabis-companies-idUSKBN1WA308

Purdue Pharma beantragt Insolvenzverfahren wegen Opioidklagen

New York – Der US-Pharmakonzern Purdue Pharma, gegen den fast 2.300 Klagen wegen seines süchtig machenden Schmerzmittels Oxycontin anhängig sind, hat Insolvenz bean­tragt. Mit dem Insolvenzverfahren nach Kapitel 11 will Purdue die Klagen beilegen, wie das Unternehmen gestern Abend in New York mitteilte. Das Unternehmen soll in eine Stiftung der öffentlichen Hand überführt werden. (aerzteblatt.de, 16.09.2019)

https://www.aerzteblatt.de/nachrichten/106009/Purdue-Pharma-beantragt-Insolvenzverfahren-wegen-Opioidklagen

USA. Deals: Purdue Nearing Deal Over Opioids as 23 States Agree to Pact

Number is less than 35 sought to make bankruptcy deal easier. Purdue moves closer to filing Chapter 11 case later this month. (Bloomberg, USA, 11.09.2019)

https://www.bloomberg.com/news/articles/2019-09-11/purdue-wins-backing-of-23-states-for-opioid-settlement

USA. Lawsuits alone will not fix the US opioid overdose crisis

The Lancet, Volume 394, Issue 10201, 805 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32041-0/fulltext

USA/Kanada. In numbers: Sackler family, Purdue Pharma and the US opioid crisis

The Sacklers have become one of the world's most controversial families. (BBC, 16.09.2019)

https://www.bbc.com/news/world-us-canada-49718388

USA. Purdue Pharma files for bankruptcy in the US

US drug-maker Purdue Pharma has filed for bankruptcy protection, as part of efforts to deal with thousands of lawsuits that accuse the firm of fuelling the US opioid crisis. (BBC, 16.09.2019)

https://www.bbc.com/news/business-49711618

USA/Kanada. Sackler family 'funnelled $1bn into different bank accounts'

The billionaire Sackler family "funnelled" at least $1bn (£800m) to different banks, including accounts in Switzerland, officials said. (BBC, 14.09.2019)

https://www.bbc.com/news/world-us-canada-49702413

USA. Purdue: Opioidkonzern erreicht vorläufigen Vergleich 

Der Pharmakonzern gilt als einer der Hauptschuldigen für die Opioid-Krise in Amerika. Nun beantragt das Unternehmen Konkurs und verteilt Gewinne auf die Kläger. Doch einige Staatsanwälte wollen deutlich mehr Geld von der Eigentümerfamilie Sackler. (faz.net, 12.09.2019)

https://www.faz.net/aktuell/wirtschaft/opioidkonzern-purdue-erreicht-vorlaeufigen-vergleich-16381372.html

USA. Purdue Pharma Tentatively Settles Thousands of Opioid Cases

The company and its owners, members of the Sackler family, have tentatively reached the first comprehensive settlement in thousands of cases nationwide. (New York Times, 11.09.2019)

https://www.nytimes.com/2019/09/11/health/purdue-pharma-opioids-settlement.html

Indivior (US): Our Commitment - Updates on the Department of Justice’s Action

We are extremely disappointed in this action by the Justice Department, which is wholly unsupported by either the facts or the law. Key allegations made by the Justice Department are contradicted by the government’s own scientific agencies, they are almost exclusively based on years-old events from before Indivior became an independent company in 2014, and they are wrong. As we fight these allegations aggressively, we are committed to remaining focused on our mission of helping patients and communities struggling with opioid addiction. (indivior.com, Stand 05.09.2019)

http://indivior.com/commitment/

USA. Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

The Sackler family is willing to give up Purdue Pharma to settle all claims related to the opioid crisis, but is resisting a quick sale of its overseas drug company.(...) The Sacklers are deep in negotiations that, if finalized, would force them to give up ownership of Purdue, the company widely blamed for the onset of the opioid epidemic with its aggressive marketing of the prescription painkiller OxyContin. But they want to keep selling OxyContin and other drugs abroad for as many as seven more years, through another company they own, Mundipharma, based in Cambridge, England. (New York Times, 30.08.2019)

https://www.nytimes.com/2019/08/30/health/purdue-sacklers-opioids-settlement.html

Philip Morris International: money over morality?

The Lancet, Volume 394, Issue 10200, 709 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31998-1/fulltext

Philip Morris and Altria Are in Talks to Merge

With Altria’s investment in Juul, a combination of the tobacco giants would dominate the international market for e-cigarettes. (New York Times, 27.08.2019)

https://www.nytimes.com/2019/08/27/health/philip-morris-altria-merger-tobacco.html

Indien. Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India

What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home. (KHN – Kaiser Health News, USA, 28.08.2019)

https://khn.org/news/india-burgeoning-chronic-pain-market-us-drugmakers-stand-to-profit

USA. Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The Sackler family would give up ownership of Purdue Pharma, the company blamed for much of the opioid epidemic, and pay $3 billion of their own money under terms of a settlement proposal to resolve thousands of federal and state lawsuits, according to a person familiar with the negotiations. (New York Times, 27.08.2019)

https://www.nytimes.com/2019/08/27/health/sacklers-purdue-pharma-opioid-settlement.html

USA. Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial

Oklahoma pursued the first case against a drug manufacturer for the national public health disaster, and the ruling may point to what lies ahead in 2,000 more lawsuits. (New York Times, 26.08.2019)

https://www.nytimes.com/2019/08/26/health/oklahoma-opioids-johnson-and-johnson.html

USA. Purdue Pharma offers $10-12 billion to settle opioid claims

The lawsuits allege the company and the Sackler family are responsible for starting and sustaining the opioid crisis. (NBC News, USA, 28.08.2019)

https://www.nbcnews.com/news/us-news/purdue-pharma-offers-10-12-billion-settle-opioid-claims-n1046526

USA. Drug makers conspired to worsen the opioid crisis. They have blood on their hands  

Johnson & Johnson and others profited from addiction and death – and yet they still don’t think they’ve done anything wrong. (The Guardian, UK, 29.08.2019)

https://www.theguardian.com/commentisfree/2019/aug/29/opioids-crisis-drug-makers-pharma

US opioid prescribing: the federal government advisers with recent ties to big pharma

BMJ2019;366doi.org/10.1136/bmj.l5167

https://www.bmj.com/content/366/bmj.l5167